血塞通联合脑复康治疗急性脑梗死疗效观察

Observation on efficacy of Xuesaitong combined with Naofukang in treatment of acute cerebral infarction

目的观察血塞通联合脑复康对急性脑梗死患者的临床疗效及安全性。方法把68例急性脑梗死患者随机分为治疗组与对照组,治疗组给予血塞通针800mg、脑复康针8.0g,每日1次,对照组给予胞二磷胆碱针0.75g、复方丹参针20ml,15d一疗程。结果临床神经功能缺损评分提示,治疗一个疗程后,治疗组神经功能改善明显。治疗组总有效率、显效率、神经功能缺损减少差值均优于对照组;两组总有效率相比有统计学差异,且未见明显副作用。结论血塞通联合脑复康是治疗急性脑梗死有效安全药物。

Objective To investigate the effect and safety of Xuesaitong combined with Naofukang in treatment of patients with acute cerebral infarction, Methods Sixty-eight patients with acute cerebral infarction were divided randomly into the treatment group and the control group, The treatment group received Xuesaitong 800mg and Naofukang 8.0g once daily while the control group received cytidine diphosphate choline 0,75g, Fufandanshen 20ml with 15 day as a treatment course, Results The clinical neurologic function damage grading indicated that after a treatment course, the neurologic function improvement in the treatment group was significant. The total effectiveness, the response rate and the improvement of the neurologic function in the treatment were significantly better than those in the control group, There was significant difference in the total effective rate between the two groups, No obvious side effects were observed. Conclusion Xuesaitong combined with Naofukang is safe and effective in treatment of acute cerebral infarction.